Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Colorectal Cancer|Metastatic Pancreatic Cancer|Metastatic Ovarian Cancer|Metastatic Breast Carcinoma|Metastatic Endocrine Tumors/ Neuroendocrine Tumors
Interventions: BIOLOGICAL: Young TIL|DRUG: Aldesleukin|DRUG: Cyclophosphamide|DRUG: Fludarabine|DRUG: Pembrolizumab (Keytruda)
Sponsor: National Cancer Institute (NCI)